US Stock Market Closed

Dashboard

Applied Therapeutics, Inc. (APLT)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity
Analyst Opinion

H

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

About

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

CEO

Shoshana Shendelman

Employees

11

Industry

Endocrinology and Metabolism Biopharmaceuticals

Sector

Healthcare

Headquarters

New York

Exchange

NASDAQ

Summary Stats

Market Cap

19.9M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 6 analysts

High

$85.00

Average

$53.00

Low

$35.00

Ratings calculated by 7 analysts

Buy

7

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Missed by -$0.05

Actual

-$0.88 -6.0%

Consensus

-0.83

Report Date

Year Ago

-1.0

Year Ago Change %

Up 12%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites